References
- Al-Mondhiry H, Pierce W S, Basarab R M. Prot-amine-induced thrombocytopenia and leukopenia. Thromb Haemost 1985; 53: 60–64
- Bagge L, Lilienberg G, Nyström S O, Tyden H. Coagulation, fibrinolysis and bleeding after open heart surgery. Scand J Thorac Cardiovasc Surg 1986; 20: 151–160
- Bonser R S, Dave J R, John L, et al. Complement activation before, during and after cardiopulmonary bypass. Eur J Cardiothorac Surg 1990; 4: 291–296
- Borowiec J, Thelin S, Bagge L, van der Linden J, Thörnö E, Hansson H E. Heparin-coated cardiopulmonary bypass circuits and 25 % reduction of heparin dose in coronary artery surgery—a clinical study. Upsala J MEd Sci 1992; 97: 55–66
- Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson H E. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass—a clinical study. J Thorac Cardiovasc Surg 1992; 104: 642–647
- Cines D B. Heparin: Do we understand its antithrombotic action? Chest 1986; 89: 429–426
- Cohen N D, Munoz A, Reitz B A, et al. Transmission of retroviruses by transfusion of screened blood in patients undergoing cardiac surgery. N Engl JMed 1989; 320: 1172–1176
- Collins J A. Problems associated with massive transfusion of stored blood. Surgery 1974; 75: 274–295
- Gravlee G P, Haddon W S, Rothberger H K, Mills S A, Rogers A T, Bean V E, et al. Heparin dosing and monitoring for cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990; 99: 518–527
- Gravlee G P, Angert K C, Tucker W Y, Case L D, Wallenhaupt S L, Cordell A R. Early anticoagulation peak and rapid distribution after intravenous heparin. Anesthesiology 1988; 68: 126–129
- Gu Y J, van Oeveren W, van der Kamp K WHJ, Akkerman C, Boonstra P W, Wildevuur C RH. Heparin-coating of extracorporeal circuits reduces thrombin formation in patients undergoing cardiopulmonary bypass. Perfusion 1991; 6: 221–225
- Harker L A. Bleeding after cardiopulmonary bypass. N Engl J Med 1986; 314: 1446–1447
- Hsu L C. Principles of heparin-coating techniques. Perfusion 1991; 6: 209–219
- Kaiser G C, Naunheim K S, Fiore A C, Harris H H, McBride L R, Pennington G, et al. Reoperation in the Intensive Care Unit. Ann Thorac Surg 1990; 49: 903–908
- Kirklin J K, Westaby S, Blackstone E H, et al. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983; 86: 845–857
- Kirklin J K, Chenoweth D E, Naftel D C, Black Stone EH, Kirklin J W, Bitran D D, et al. Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. Ann Thorac Surg 1986; 41: 193–199
- Larm O, Larsson R, Olsson P. A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue. Biomat Med Dev Art Org 1983; 11: 161–173
- Nilsson L, Storm K E, Thelin S, et al. Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig. Artificial organs 1990; 14: 46–48
- Nilsson L, Brunnkvist S, Nilsson U, et al. Activation of inflammatory systems during cardiopulmonary bypass. Scand J Thor Cardiovasc Surg 1988; 22: 51–53
- Salo M. Immunosuppressive effects of blood transfusion in anaesthesia and surgery. Acta Anaesthesiol Scand 1988; 32(Supplementum 89)26–34
- Segesser L K, Weiss B M, Garcia E, Gallino A, Turina M. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization. Eur J Cardiothorac Surg 1990; 4: 639–643
- Thelin S, Bagge L, Hultman J, Borowiec J, Nilsson L, Thorelius J. Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma. Experiments in the pig. Eur J Cardiothorac Surg 1991; 5: 486–491
- van Oeveren W, Kazatchkine M D, Descamps-Latscha B, et al. Deleterious effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1985; 89: 888–899
- Woodman R C, Harker L A. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 9: 1680–1697
- Yap P L. Transfusion transmitted viral infections—recent developments in blood donor screening. Postgrad Med J 1990; 66: 906–909
- Övrum E, Lindberg H, ÅmHolem E, Abdelnoor M, Bech J. Systemic and pulmonary circulatory effects of protamine following cardiopulmonary bypass in man. Scand J Thor Cardiovasc Surg 1991; 25: 19–24